The body's own regulation of a particular gene is associated with a reduced risk of developing post-traumatic stress disorder after a terrible experience.
A series of 22 autopsies showed that heart damage in COVID-19 deaths had a particular cell death pattern of individual cardiac myocytes and not the typical heart muscle inflammation associated with myocarditis.
A summer camp in Georgia (USA) became a major SARS-CoV-2 cluster. At least 260 of its 597 attendants tested positive. The discovery confirms that children can contract the virus and play a key role in its spread.
"scVelo" is a machine learning-based open software that predicts gene activity in individual cells. This could allow predicting the future state of individual cells and to better understand the course of a disease.
A team is investigating how some semiochemicals involved in the body's "fight-or-flight reaction" impact immune cells. They aim to further explain how stress can make humans more susceptible to infections or cancer.
According to current studies, the advantages in endpoint categories such as mortality, morbidity, and health-related quality of life are not offset by disadvantages in darolutamide treatment.
According to a study, several species of Asia-endemic mosquitoes are spreading in Tyrol. This increases the transmission risk of dangerous viruses such as Dengue, Chikungunya, and Zika.
Modern genetic testing methods improve the diagnosis of rare diseases. This is confirmed by a study in which over 7,000 rare diseases patients were examined and the entire genome was sequenced.
A new project is developing a software that automatically searches CT images for suspicious signs of critical symptoms, alerting the treating physician of developing complications.
Researchers at the Justus Liebig University in Giessen (Germany) are investigating the brain’s influence in the desire for high-calorie sweet and savory foods just before menstruation.
Online training could improve asthma patients’ knowledge of their chronic disease just as well as conventional training, hinting at new approaches to future treatments.
Dr. Paul Sargos (Institute Bergonie, Bordeaux, France) presented the first results of the GETUG-AFU 22 study and won the second prize in the EAU20 Best Abstract Awards Oncology.
Research teams are increasingly trying to use the body's own immune system to fight cancer. A new study is helping to better understand the "arms race" between immune defenses and the disease, and may help improve modern therapeutic approaches.
Researchers show that water loss in the cell, the so-called osmotic stress, sets in motion cellular waste disposal, which occurs through an interaction of autophagy and lysosomes; with implications for neurodegenerative diseases.
The EUPROMS study represents the first patient-driven quality-of-life (QoL) data collection and revealed specific long-term complaints correlating with a given treatment.
Researchers found that medication and psychotherapy do not differ in the acute treatment of individual symptoms. The researchers' goal remains to develop a more individually adapted therapy.
Recent studies suggest that steroid sulfatase (STS) can drive prostate cancer and initiate resistance through an alternative androgen synthesis.
Some people are better protected against UTIs because their bodies produce higher levels of uromodulin. A research team discovered how the helper protein works, with possible implications for UTI treatment and prevention.
A 10-years single-center study reported that substantially more men complain of reduced sexual desire than a decade ago. Conversely, fewer men complain of erectile dysfunction and premature ejaculation.
New findings show that urosepsis is associated with lower mortality than sepsis derived from other sites, but if appropriate measures are not taken, 10-15% will develop a recurrent urosepsis.